Jodas Expoim Pvt. Ltd.
www.jodasexpoim.inJodas is a global, specialty, innovation-driven, emerging, generic pharmaceutical company, that is asserting itself among the world’s foremost pharmaceutical companies. We began our journey of growth in the year 2008 in India, and today Jodas is a modern, research-driven organization that has quality and affordability at the heart of its activities. Our Core Therapeutic Segments: Anti Infectives (Injectables) Anti Cancer (Injectables & Orals) Contrast Media – Injectables Critical Care (Injectables & Orals) Our dedicated team of healthcare professionals strives to bring specialty, high-quality, effective, and affordable generic formulations to the market, touching millions of lives with good health. Jodas has approved products in 30+ countries with State-of-the-art world-class manufacturing facilities and has successfully commercialized 19.4 million Injectables in the year 2022, with unparalleled customer satisfaction. The future endeavor is to be a Global generic player, validating our commitment “ONE STEP BETTER”, to fulfill the unmet medical needs of the healthcare community around the Globe with specialty generic formulations of uncompromising quality.
Read moreJodas is a global, specialty, innovation-driven, emerging, generic pharmaceutical company, that is asserting itself among the world’s foremost pharmaceutical companies. We began our journey of growth in the year 2008 in India, and today Jodas is a modern, research-driven organization that has quality and affordability at the heart of its activities. Our Core Therapeutic Segments: Anti Infectives (Injectables) Anti Cancer (Injectables & Orals) Contrast Media – Injectables Critical Care (Injectables & Orals) Our dedicated team of healthcare professionals strives to bring specialty, high-quality, effective, and affordable generic formulations to the market, touching millions of lives with good health. Jodas has approved products in 30+ countries with State-of-the-art world-class manufacturing facilities and has successfully commercialized 19.4 million Injectables in the year 2022, with unparalleled customer satisfaction. The future endeavor is to be a Global generic player, validating our commitment “ONE STEP BETTER”, to fulfill the unmet medical needs of the healthcare community around the Globe with specialty generic formulations of uncompromising quality.
Read moreCountry
City (Headquarters)
Kūkatpalli
Industry
Employees
501-1000
Founded
2006
Social
Employees statistics
View all employeesPotential Decision Makers
Senior Executive
Email ****** @****.comPhone (***) ****-****Senior Executive
Email ****** @****.comPhone (***) ****-****Senior Executive Qc Microbiology
Email ****** @****.comPhone (***) ****-****Director - Human Resources
Email ****** @****.comPhone (***) ****-****
Technologies
(21)